لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Li, Ying, Liu, Wei, Xu, Yun, Guo, Lan-Yan, Weng, You-Liang, Huang, Zong-Wei, Chen, Xiao-Chuan, Lin, Ting, Lu, Jun, Qiu, Su-Fang

مصطلحات موضوعية: 110320 Radiology and Organ Imaging, FOS: Clinical medicine, Biochemistry, 111299 Oncology and Carcinogenesis not elsewhere classified

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e7a6f60edb6785164135b69262f99c1

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Qiu SF; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014, China., Zhang QZ; Berry Oncology Corporation, Beijing, 100102, China., Wu ZY; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China., Liu MZ; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China., Ding Q; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014, China., Sun FM; Berry Oncology Corporation, Beijing, 100102, China., Wang Y; Berry Oncology Corporation, Beijing, 100102, China; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, 350200, China., Yang HX; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014, China., Zheng L; Berry Oncology Corporation, Beijing, 100102, China., Chen X; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China., Wu L; Berry Oncology Corporation, Beijing, 100102, China., Bai J; Berry Oncology Corporation, Beijing, 100102, China; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, 350200, China. Electronic address: baijian488@berryoncology.com., Liu JF; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014, China. Electronic address: drjingfeng@fjmu.edu.cn., Chen CB; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Provincial Key Laboratory of Tumor Biotherapy Fuzhou, 350200, China. Electronic address: ccb@fjmu.edu.cn.

المصدر: EBioMedicine [EBioMedicine] 2024 Sep 11; Vol. 108, pp. 105321. Date of Electronic Publication: 2024 Sep 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

المؤلفون: Zheng W; Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou, China E-mail : panjianji@aliyun.com., Xu YJ, Qiu SF, Zong JF, Huang LL, Huang CB, Lin SJ, Pan JJ

المصدر: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2015; Vol. 16 (10), pp. 4393-9.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Asian Pacific Organization for Cancer Prevention Country of Publication: Thailand NLM ID: 101130625 Publication Model: Print Cited Medium: Internet ISSN: 2476-762X (Electronic) Linking ISSN: 15137368 NLM ISO Abbreviation: Asian Pac J Cancer Prev Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Squamous Cell/*secondary , Carcinoma, Squamous Cell/*therapy , Nasopharyngeal Neoplasms/*pathology , Nasopharyngeal Neoplasms/*therapy , Neoplasm Recurrence, Local/*pathology, Cisplatin/administration & dosage ; Combined Modality Therapy ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Disease-Free Survival ; Dose Fractionation, Radiation ; Female ; Fluorouracil/administration & dosage ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Staging ; Paclitaxel/administration & dosage ; Proportional Hazards Models ; Radiotherapy, Intensity-Modulated ; Risk Factors ; Gemcitabine